首页 > 最新文献

Praxis最新文献

英文 中文
[What do Swiss people know about cardiovascular risk factors?] [瑞士人对心血管危险因素了解多少?]
Q4 Medicine Pub Date : 2025-03-01 DOI: 10.23785/PRAXIS.2025.03.003
Thomas Rosemann, Thomas F Lüscher, Andrea Rosemann

Introduction: Cardiovascular diseases are associated with a high morbidity burden in Switzerland and are the leading cause of death. Important cardiovascular risk factors such as hypertension, hyperlipidemia and diabetes can be treated extremely effectively with medication. A prerequisite for good therapy adherence is that those affected have sufficient knowledge. An anonymized online questionnaire was distributed via a health magazine and answered by 3166 participants. The majority of participants, 61.2 % (1902), were between 59 and 79 old. 2584 participants (83.1 %) were of the opinion that cardiovascular diseases can be well treated with medication. 1,781 (64.3 %) stated that they knew their blood pressure very precisely and 1,086 (39.25) stated that they knew their cholesterol value very precisely. 697 (25.2 %) did not know their cholesterol value or blood pressure (71; 2.6 %). When it comes to risk factors, smoking was classified as the most important factor (statement "strong" or "very strong": 2102; 77.6 %), almost on a par with blood pressure (2081, 77 %), lack of exercise (2047; 75.6 %) and Cholesterol (1906; 70.4 %). Overall, our survey shows that the Swiss have a comparatively good orientation about cardiovascular risk factors. However, even in our sample, which is certainly very health-conscious, there is still a clear need for education. However, our results also show that the majority are willing to implement preventative measures using medication.

导言:在瑞士,心血管疾病的发病率很高,是导致死亡的主要原因。重要的心血管危险因素,如高血压、高脂血症和糖尿病,可以通过药物非常有效地治疗。良好的治疗依从性的先决条件是受影响的人有足够的知识。一份匿名在线调查问卷通过一家健康杂志发放,共有3166名参与者回答。大多数参与者,61.2%(1902),年龄在59岁到79岁之间。2584名参与者(83.1%)认为心血管疾病可以通过药物很好地治疗。1781人(64.3%)表示他们非常精确地知道自己的血压,1086人(39.25%)表示他们非常精确地知道自己的胆固醇值。697(25.2%)不知道自己的胆固醇值或血压(71;2.6%)。当涉及到风险因素时,吸烟被列为最重要的因素(陈述“强烈”或“非常强烈”:2102;77.6%),几乎与血压(2081,77%)、缺乏运动(2047;75.6%)和胆固醇(1906;70.4%)。总的来说,我们的调查显示瑞士人对心血管危险因素有比较好的认识。然而,即使在我们的样本中,当然非常注重健康,仍然明显需要教育。然而,我们的结果也表明,大多数人愿意使用药物实施预防措施。
{"title":"[What do Swiss people know about cardiovascular risk factors?]","authors":"Thomas Rosemann, Thomas F Lüscher, Andrea Rosemann","doi":"10.23785/PRAXIS.2025.03.003","DOIUrl":"10.23785/PRAXIS.2025.03.003","url":null,"abstract":"<p><strong>Introduction: </strong>Cardiovascular diseases are associated with a high morbidity burden in Switzerland and are the leading cause of death. Important cardiovascular risk factors such as hypertension, hyperlipidemia and diabetes can be treated extremely effectively with medication. A prerequisite for good therapy adherence is that those affected have sufficient knowledge. An anonymized online questionnaire was distributed via a health magazine and answered by 3166 participants. The majority of participants, 61.2 % (1902), were between 59 and 79 old. 2584 participants (83.1 %) were of the opinion that cardiovascular diseases can be well treated with medication. 1,781 (64.3 %) stated that they knew their blood pressure very precisely and 1,086 (39.25) stated that they knew their cholesterol value very precisely. 697 (25.2 %) did not know their cholesterol value or blood pressure (71; 2.6 %). When it comes to risk factors, smoking was classified as the most important factor (statement \"strong\" or \"very strong\": 2102; 77.6 %), almost on a par with blood pressure (2081, 77 %), lack of exercise (2047; 75.6 %) and Cholesterol (1906; 70.4 %). Overall, our survey shows that the Swiss have a comparatively good orientation about cardiovascular risk factors. However, even in our sample, which is certainly very health-conscious, there is still a clear need for education. However, our results also show that the majority are willing to implement preventative measures using medication.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 3","pages":"86-91"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143649530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Vitamin K2 reduces the frequency of nocturnal leg cramps in the elderly]. [维生素K2可以减少老年人夜间腿部抽筋的频率]。
Q4 Medicine Pub Date : 2025-02-01 DOI: 10.23785/PRAXIS.2025.02.001
Johann Steurer

Introduction:

作品简介:
{"title":"[Vitamin K2 reduces the frequency of nocturnal leg cramps in the elderly].","authors":"Johann Steurer","doi":"10.23785/PRAXIS.2025.02.001","DOIUrl":"10.23785/PRAXIS.2025.02.001","url":null,"abstract":"<p><strong>Introduction: </strong></p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 2","pages":"46"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Fever and Pancytopenia - not Always a Case for Oncology]. [发烧和全血细胞减少症-并非总是肿瘤病例]。
Q4 Medicine Pub Date : 2025-02-01 DOI: 10.23785/PRAXIS.2025.02.008
Stephanie Kirch, Reto Kühne, Adrian Schibli, Felix Grimm, Corina Ebnöther

Introduction: The article describes the case of a 68-year-old patient who was admitted to a clinic after returning from southern Italy with fever, night sweats, and pancytopenia. After extensive diagnostic investigations that ruled out bacterial, viral, and parasitic infections as well as other diseases, visceral leishmaniasis (VL) were eventually diagnosed. This diagnosis was confirmed by the detection of Leishmania sp. in the bone marrow and positive serological tests. Additionally, the patient showed signs of macrophage activation syndrome (MAS), a severe inflammatory reaction that often occurs as a complication of infections or rheumatological diseases. The treatment included liposomal amphotericin B for leishmaniasis as well as steroids and etoposide for the treatment of MAS. The patient recovered after treatment and showed an improvement in general condition during follow-up examinations. The article emphasizes the challenge of correctly diagnosing VL and MAS, especially in combination, particularly in patients outside endemic areas. Rapid diagnosis is crucial, as delays can worsen the prognosis in these severe diseases.

简介:本文描述了一个68岁的病人,他从意大利南部返回后因发烧、盗汗和全血细胞减少症被送入一家诊所。经过广泛的诊断调查,排除了细菌、病毒和寄生虫感染以及其他疾病,内脏利什曼病(VL)最终被诊断出来。骨髓中检测到利什曼原虫和血清学试验阳性证实了这一诊断。此外,患者表现出巨噬细胞激活综合征(MAS)的迹象,这是一种严重的炎症反应,通常作为感染或风湿病的并发症发生。治疗包括利什曼病的脂质体两性霉素B和治疗MAS的类固醇和依托泊苷。患者经治疗后恢复,随访时一般情况好转。文章强调了正确诊断VL和MAS的挑战,特别是合并诊断,特别是在流行地区以外的患者中。快速诊断至关重要,因为延误会使这些严重疾病的预后恶化。
{"title":"[Fever and Pancytopenia - not Always a Case for Oncology].","authors":"Stephanie Kirch, Reto Kühne, Adrian Schibli, Felix Grimm, Corina Ebnöther","doi":"10.23785/PRAXIS.2025.02.008","DOIUrl":"10.23785/PRAXIS.2025.02.008","url":null,"abstract":"<p><strong>Introduction: </strong>The article describes the case of a 68-year-old patient who was admitted to a clinic after returning from southern Italy with fever, night sweats, and pancytopenia. After extensive diagnostic investigations that ruled out bacterial, viral, and parasitic infections as well as other diseases, visceral leishmaniasis (VL) were eventually diagnosed. This diagnosis was confirmed by the detection of Leishmania sp. in the bone marrow and positive serological tests. Additionally, the patient showed signs of macrophage activation syndrome (MAS), a severe inflammatory reaction that often occurs as a complication of infections or rheumatological diseases. The treatment included liposomal amphotericin B for leishmaniasis as well as steroids and etoposide for the treatment of MAS. The patient recovered after treatment and showed an improvement in general condition during follow-up examinations. The article emphasizes the challenge of correctly diagnosing VL and MAS, especially in combination, particularly in patients outside endemic areas. Rapid diagnosis is crucial, as delays can worsen the prognosis in these severe diseases.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 2","pages":"72-74"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Progress in the treatment of ovarian cancer]. [卵巢癌治疗的进展]。
Q4 Medicine Pub Date : 2025-02-01 DOI: 10.23785/PRAXIS.2025.02.005
Isabell Witzel, E Pierre Samartzis, Ahmed El-Balat

Introduction: Of all gynaecological tumours, ovarian cancer has the highest mortality rate because it is often not diagnosed until the tumour is at an advanced stage due to the lack of early symptoms and suitable screening tests. The aim of this paper is to examine the current state of diagnosis and therapy.

简介:在所有妇科肿瘤中,卵巢癌的死亡率最高,因为由于缺乏早期症状和适当的筛查试验,通常要到肿瘤处于晚期才诊断出来。本文的目的是检查诊断和治疗的现状。
{"title":"[Progress in the treatment of ovarian cancer].","authors":"Isabell Witzel, E Pierre Samartzis, Ahmed El-Balat","doi":"10.23785/PRAXIS.2025.02.005","DOIUrl":"10.23785/PRAXIS.2025.02.005","url":null,"abstract":"<p><strong>Introduction: </strong>Of all gynaecological tumours, ovarian cancer has the highest mortality rate because it is often not diagnosed until the tumour is at an advanced stage due to the lack of early symptoms and suitable screening tests. The aim of this paper is to examine the current state of diagnosis and therapy.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 2","pages":"56-60"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[VEXAS syndrome - a chameleon of inflammatory syndromes]. [VEXAS综合征-炎症综合征的变色龙]。
Q4 Medicine Pub Date : 2025-02-01 DOI: 10.23785/PRAXIS.2025.02.009
Elisa Leggeri, Athina Pangalu, Florence Vallelian

Introduction: The VEXAS syndrome is a systemic autoinflammatory disease first described in 2020. It primarily affects older men and is caused by a somatic mutation in the UBA1 gene on the X chromosome, leading to dysfunction of the innate immune system. Symptoms include fever, weight loss, various hematological manifestations, and a broad spectrum of clinical symptoms, often including ocular manifestations. Diagnosis is based on the detection of the mutation. There is currently no standardized therapy, and mortality can be as high as 40 %.

简介:VEXAS综合征是一种全身性自身炎症性疾病,于2020年首次被描述。它主要影响老年男性,由X染色体上UBA1基因的体细胞突变引起,导致先天免疫系统功能障碍。症状包括发热、体重减轻、各种血液学表现和广泛的临床症状,通常包括眼部表现。诊断是基于对突变的检测。目前尚无标准化的治疗方法,死亡率可高达40%。
{"title":"[VEXAS syndrome - a chameleon of inflammatory syndromes].","authors":"Elisa Leggeri, Athina Pangalu, Florence Vallelian","doi":"10.23785/PRAXIS.2025.02.009","DOIUrl":"10.23785/PRAXIS.2025.02.009","url":null,"abstract":"<p><strong>Introduction: </strong>The VEXAS syndrome is a systemic autoinflammatory disease first described in 2020. It primarily affects older men and is caused by a somatic mutation in the UBA1 gene on the X chromosome, leading to dysfunction of the innate immune system. Symptoms include fever, weight loss, various hematological manifestations, and a broad spectrum of clinical symptoms, often including ocular manifestations. Diagnosis is based on the detection of the mutation. There is currently no standardized therapy, and mortality can be as high as 40 %.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 2","pages":"75-79"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[REM-Sleep-Behavior Disorder - More Than a Simple Parasomnia]. [快速眼动睡眠行为障碍-不仅仅是简单的睡眠异常]。
Q4 Medicine Pub Date : 2025-02-01 DOI: 10.23785//PRAXIS.2025.02.004
Carolin Schäfer, Anne-Kathrin Brill, Marie-Angela Wulf, Markus Schmidt, Claudio L Bassetti

Introduction: Rapid-Eye-Movement (REM) sleep is an essential part of sleep dominating the second half of the night. A disturbance of the phy-siological muscle hypotonia of REM sleep can lead to dream enactment: REM sleep behavior disorder (RBD). In the absence of a disease of the central nervous system or provoking factors such as sleep apnea, alcohol consumption or antidepressants, isolated RBD (iRBD) may be present. IRBD is an early stage of alpha-synucleinopathies such as Parkinson's disease, dementia with Lewy bodies and multisystem atrophy. Medical history and polysomnography are the most important diagnostic tools. Clonazepam and melatonin are symptomatic treatments used to prevent injury. New technologies enable long-term monitoring of disease progression in iRBD and thus guide the targeted use of future disease-modifying therapies.

简介:快速眼动(REM)睡眠是睡眠的重要组成部分,主宰着下半晚的睡眠。快速眼动睡眠的生理性肌肉张力低下会导致做梦:快速眼动睡眠行为障碍(RBD)。在没有中枢神经系统疾病或诱发因素(如睡眠呼吸暂停、饮酒或抗抑郁药)的情况下,孤立性RBD (iRBD)可能存在。IRBD是α -突触核蛋白病的早期阶段,如帕金森病、路易体痴呆和多系统萎缩。病史和多导睡眠图是最重要的诊断工具。氯硝西泮和褪黑素是用来防止受伤的对症治疗。新技术能够长期监测iRBD的疾病进展,从而指导有针对性地使用未来的疾病修饰疗法。
{"title":"[REM-Sleep-Behavior Disorder - More Than a Simple Parasomnia].","authors":"Carolin Schäfer, Anne-Kathrin Brill, Marie-Angela Wulf, Markus Schmidt, Claudio L Bassetti","doi":"10.23785//PRAXIS.2025.02.004","DOIUrl":"10.23785//PRAXIS.2025.02.004","url":null,"abstract":"<p><strong>Introduction: </strong>Rapid-Eye-Movement (REM) sleep is an essential part of sleep dominating the second half of the night. A disturbance of the phy-siological muscle hypotonia of REM sleep can lead to dream enactment: REM sleep behavior disorder (RBD). In the absence of a disease of the central nervous system or provoking factors such as sleep apnea, alcohol consumption or antidepressants, isolated RBD (iRBD) may be present. IRBD is an early stage of alpha-synucleinopathies such as Parkinson's disease, dementia with Lewy bodies and multisystem atrophy. Medical history and polysomnography are the most important diagnostic tools. Clonazepam and melatonin are symptomatic treatments used to prevent injury. New technologies enable long-term monitoring of disease progression in iRBD and thus guide the targeted use of future disease-modifying therapies.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 2","pages":"51-55"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Two Different Courses of a Rare, Potentially Reversible Encephalopathy]. [一种罕见的、可能可逆的脑病的两种不同病程]。
Q4 Medicine Pub Date : 2025-02-01 DOI: 10.23785/PRAXIS.2025.02.007
Dominik Imhoff, Rolf Sturzenegger, Philip Went, Georgios Pantazis

Introduction: Cerebral amyloid angiopathy-related inflammation (CAA-RI) is a rare form of cerebral amyloid angiopathy (CAA). This leads to amyloid deposits and inflammation in the vessel walls with cerebral microbleeds, white matter hyperintensities and edema. Major clinical manifestations vary and are non-specific. They include rapidly progressive dementia, headaches and epileptic seizures. MRI and histology are crucial for further diagnosis, although the definitive diagnosis can only be made in autopsy. Timely therapy, mainly with corticosteroids, is essential for successful healing.

脑淀粉样血管病相关炎症(CAA- ri)是一种罕见的脑淀粉样血管病(CAA)。这导致淀粉样蛋白沉积和血管壁炎症,伴有脑微出血、白质高信号和水肿。主要临床表现各不相同,无特异性。它们包括快速进行性痴呆、头痛和癫痫发作。MRI和组织学对进一步诊断至关重要,尽管最终诊断只能在尸检中做出。及时治疗,主要是使用皮质类固醇,对成功愈合至关重要。
{"title":"[Two Different Courses of a Rare, Potentially Reversible Encephalopathy].","authors":"Dominik Imhoff, Rolf Sturzenegger, Philip Went, Georgios Pantazis","doi":"10.23785/PRAXIS.2025.02.007","DOIUrl":"10.23785/PRAXIS.2025.02.007","url":null,"abstract":"<p><strong>Introduction: </strong>Cerebral amyloid angiopathy-related inflammation (CAA-RI) is a rare form of cerebral amyloid angiopathy (CAA). This leads to amyloid deposits and inflammation in the vessel walls with cerebral microbleeds, white matter hyperintensities and edema. Major clinical manifestations vary and are non-specific. They include rapidly progressive dementia, headaches and epileptic seizures. MRI and histology are crucial for further diagnosis, although the definitive diagnosis can only be made in autopsy. Timely therapy, mainly with corticosteroids, is essential for successful healing.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 2","pages":"66-71"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Brucellose as a travel souvenir]. [作为旅游纪念品的布鲁塞尔]。
Q4 Medicine Pub Date : 2025-02-01 DOI: 10.23785/PRAXIS.2025.02.010
Valentino Monaco, Michael Bodmer, Andrea Christina Frey

Introduction: Family with fever, asthenia, arthralgia and headache after travelling back from Kosovo. A precise exposure history led to the suspicion of an underlying zoonosis and allowed a diagnosis to be made. The treatment with doxycycline and gentamicin led to a restitutio ad integrum in all family members.

简介:一家人从科索沃旅行回来后出现发热、乏力、关节痛和头痛。准确的接触史导致怀疑潜在的人畜共患病,并允许作出诊断。多西环素和庆大霉素治疗导致所有家庭成员的恢复和整合。
{"title":"[Brucellose as a travel souvenir].","authors":"Valentino Monaco, Michael Bodmer, Andrea Christina Frey","doi":"10.23785/PRAXIS.2025.02.010","DOIUrl":"10.23785/PRAXIS.2025.02.010","url":null,"abstract":"<p><strong>Introduction: </strong>Family with fever, asthenia, arthralgia and headache after travelling back from Kosovo. A precise exposure history led to the suspicion of an underlying zoonosis and allowed a diagnosis to be made. The treatment with doxycycline and gentamicin led to a restitutio ad integrum in all family members.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 2","pages":"80-82"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Statins are not associated with an increased risk of cataracts in patients at risk of cardiovascular disease]. [他汀类药物与有心血管疾病风险的患者白内障风险增加无关]。
Q4 Medicine Pub Date : 2025-02-01 DOI: 10.23785/PRAXIS.2025.02.002
Thomas Rosemann, Andrea Rosemann

Introduction:

作品简介:
{"title":"[Statins are not associated with an increased risk of cataracts in patients at risk of cardiovascular disease].","authors":"Thomas Rosemann, Andrea Rosemann","doi":"10.23785/PRAXIS.2025.02.002","DOIUrl":"10.23785/PRAXIS.2025.02.002","url":null,"abstract":"<p><strong>Introduction: </strong></p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 2","pages":"47"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Summary of the 2024 ESC-Guidelines for the management of elevated blood pressure and hypertension]. 【2024年esc -高血压和高血压治疗指南摘要】。
Q4 Medicine Pub Date : 2025-02-01 DOI: 10.23785/PRAXIS.2025.02.003
Miklos Rohla, Emrush Rexhaj

Introduction: This mini-review summarizes the new guideline recommendations of the European Society of Cardiology for the management of elevated blood pressure and hypertension - with particular focus on aspects relevant to daily clinical practice.

简介:这篇小型综述总结了欧洲心脏病学会关于高血压和高血压管理的新指南建议,特别关注与日常临床实践相关的方面。
{"title":"[Summary of the 2024 ESC-Guidelines for the management of elevated blood pressure and hypertension].","authors":"Miklos Rohla, Emrush Rexhaj","doi":"10.23785/PRAXIS.2025.02.003","DOIUrl":"10.23785/PRAXIS.2025.02.003","url":null,"abstract":"<p><strong>Introduction: </strong>This mini-review summarizes the new guideline recommendations of the European Society of Cardiology for the management of elevated blood pressure and hypertension - with particular focus on aspects relevant to daily clinical practice.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"114 2","pages":"48-50"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Praxis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1